← Back to search results

planningFind a Tender · planning
BuyerUniversity Hospitals Birmingham NHS Foundation Trust
Statusplanning
DeadlineNot published
ValueValue not published
Published5 Jun 2026

What is being bought

Managed service to support laboratory work in the Immunology department at UHB. The contract would provide an efficient and effective solution to minimise manual processes and, where possible, utilise automated solutions to future-proof the service for our users. At the time of this notice the Immunology Manged Service would cover automated solutions to the following: a. Allergy serology o Fluorescent enzyme immunoassay to include: i. Total and specific IgE ii. Component allergy testing iii. Tryptase iv. Specific IgG / precipitins b. Autoimmunity o Indirect immunofluorescence o Enzyme immunoassay / ELISA o Immunoblot c. Cellular Immunology / Immunodeficiency o Flow cytometry (including single & dual platform) o ELISA d. Immunochemistry o Capillary Zone electrophoresis o Gel immunofixation o Iso-electric focussing o Turbidimetry e. Infectious Immunology o Including automated ELISA IGRA for latent TB

Categories

Medical equipments 33100000

Lot details

Lot 1

No lot description published.

Statusplanning
Contract periodFrom 1 Jul 2027 to 30 Jun 2029

What is included

ItemCategoryQuantity
1Medical equipmentsNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Medical equipments (33100000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 333,3862 median · 114.5 average (1,477 of 3,386 with a bid count)5.9 average (1,758 of 3,386 with named award suppliers)Not published
Same buyer5Not publishedNot publishedNot published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetValue not published
No-engagement rationaleNot published
Planning documents1
Planning milestones1
MilestoneTypeDueStatus
BBCS intends to undertake a programme of pre-market engagement across the dates of 21/07/2026 – 05/08/2026. BBCS will make a final decision on the most appropriate route to market following completion of this engagement activity. As part of this process, interested suppliers will be invited to attend a site visit to the Immunology laboratory. This site visit will be scheduled for either 21/07/2026 or 22/07/2026. This visit is intended to allow suppliers to gain an understanding of the current laboratory environment, operational workflows and space constraints within the existing laboratory. Following the site visits, suppliers will be invited to a slot to attend a virtual engagement session, and deliver a short presentation addressing points which BBCS wishes to explore. The presentations will be scheduled for either 04/08/2026 or 05/08/2026. Details of the exact date and allocated time slot for the site visit and presentation will be sent to you via the Atamis portal, and all subsequent invites and information will also be provided here following the closing date. Atamis portal reference: C451727 - “UHB Immunology Managed Service - MARKET ENGAGEMENT 2026/27”engagement3 Jul 2026scheduled

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-06af0f
Latest release ID053486-2026
Latest release timestampFri Jun 05 2026 15:01:35 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanning
Procurement methodNot published
Procurement method detailsNot published
Main procurement categorygoods
Above thresholdYes
Legal basis2023/54
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
5 Jun 2026planning053486-2026

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "053486-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-06-05T16:01:35+01:00",
  "ocid": "ocds-h6vhtk-06af0f",
  "buyer": {
    "id": "GB-PPON-PWVL-6877-BXXV",
    "name": "University Hospitals Birmingham NHS Foundation Trust"
  },
  "tender": {
    "id": "C451727",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "contractPeriod": {
          "endDate": "2029-06-30T23:59:59+01:00",
          "startDate": "2027-07-01T00:00:00+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "33100000",
            "scheme": "CPV",
            "description": "Medical equipments"
          }
        ]
      }
    ],
    "title": "UHB Immunology Managed Service",
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "Managed service to support laboratory work in the Immunology department at UHB. The contract would provide an efficient and effective solution to minimise manual processes and, where possible, utilise automated solutions to future-proof the service for our users.\nAt the time of this notice the Immunology Manged Service would cover automated solutions to the following:\na. Allergy serology\no Fluorescent enzyme immunoassay to include:\ni. Total and specific IgE\nii. Component allergy testing\niii. Tryptase\niv. Specific IgG / precipitins\nb. Autoimmunity\no Indirect immunofluorescence \no Enzyme immunoassay / ELISA\no Immunoblot\nc. Cellular Immunology / Immunodeficiency \no Flow cytometry (including single & dual platform)\no ELISA\nd. Immunochemistry\no Capillary Zone electrophoresis\no Gel immunofixation\no Iso-electric focussing \no Turbidimetry\ne. Infectious Immunology\no Including automated ELISA IGRA for latent TB",
    "communication": {
      "futureNoticeDate": "2026-09-25T23:59:59+01:00"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods",
    "additionalProcurementCategories": [
      "services"
    ]
  },
  "parties": [
    {
      "id": "GB-PPON-PWVL-6877-BXXV",
      "name": "University Hospitals Birmingham NHS Foundation Trust",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKG31",
        "country": "GB",
        "locality": "Birmingham",
        "postalCode": "B15 2GW",
        "countryName": "United Kingdom",
        "streetAddress": "Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston"
      },
      "details": {
        "url": "https://www.uhb.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PWVL-6877-BXXV",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Jack Gosling",
        "email": "jack.gosling@uhb.nhs.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "053486-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/053486-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-06-05T16:01:35+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-07-03T23:59:59+01:00",
        "description": "BBCS intends to undertake a programme of pre-market engagement across the dates of 21/07/2026 – 05/08/2026. BBCS will make a final decision on the most appropriate route to market following completion of this engagement activity.\nAs part of this process, interested suppliers will be invited to attend a site visit to the Immunology laboratory. This site visit will be scheduled for either 21/07/2026 or 22/07/2026. This visit is intended to allow suppliers to gain an understanding of the current laboratory environment, operational workflows and space constraints within the existing laboratory.\nFollowing the site visits, suppliers will be invited to a slot to attend a virtual engagement session, and deliver a short presentation addressing points which BBCS wishes to explore. The presentations will be scheduled for either 04/08/2026 or 05/08/2026.\nDetails of the exact date and allocated time slot for the site visit and presentation will be sent to you via the Atamis portal, and all subsequent invites and information will also be provided here following the closing date.\nAtamis portal reference: \nC451727 - “UHB Immunology Managed Service - MARKET ENGAGEMENT 2026/27”"
      }
    ]
  },
  "initiationType": "tender"
}
Complete JSON history (1 releases)
5 Jun 2026 · 053486-2026 · planning
{
  "id": "053486-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-06-05T16:01:35+01:00",
  "ocid": "ocds-h6vhtk-06af0f",
  "buyer": {
    "id": "GB-PPON-PWVL-6877-BXXV",
    "name": "University Hospitals Birmingham NHS Foundation Trust"
  },
  "tender": {
    "id": "C451727",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "contractPeriod": {
          "endDate": "2029-06-30T23:59:59+01:00",
          "startDate": "2027-07-01T00:00:00+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "33100000",
            "scheme": "CPV",
            "description": "Medical equipments"
          }
        ]
      }
    ],
    "title": "UHB Immunology Managed Service",
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "Managed service to support laboratory work in the Immunology department at UHB. The contract would provide an efficient and effective solution to minimise manual processes and, where possible, utilise automated solutions to future-proof the service for our users.\nAt the time of this notice the Immunology Manged Service would cover automated solutions to the following:\na. Allergy serology\no Fluorescent enzyme immunoassay to include:\ni. Total and specific IgE\nii. Component allergy testing\niii. Tryptase\niv. Specific IgG / precipitins\nb. Autoimmunity\no Indirect immunofluorescence \no Enzyme immunoassay / ELISA\no Immunoblot\nc. Cellular Immunology / Immunodeficiency \no Flow cytometry (including single & dual platform)\no ELISA\nd. Immunochemistry\no Capillary Zone electrophoresis\no Gel immunofixation\no Iso-electric focussing \no Turbidimetry\ne. Infectious Immunology\no Including automated ELISA IGRA for latent TB",
    "communication": {
      "futureNoticeDate": "2026-09-25T23:59:59+01:00"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods",
    "additionalProcurementCategories": [
      "services"
    ]
  },
  "parties": [
    {
      "id": "GB-PPON-PWVL-6877-BXXV",
      "name": "University Hospitals Birmingham NHS Foundation Trust",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKG31",
        "country": "GB",
        "locality": "Birmingham",
        "postalCode": "B15 2GW",
        "countryName": "United Kingdom",
        "streetAddress": "Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston"
      },
      "details": {
        "url": "https://www.uhb.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PWVL-6877-BXXV",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Jack Gosling",
        "email": "jack.gosling@uhb.nhs.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "053486-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/053486-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-06-05T16:01:35+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-07-03T23:59:59+01:00",
        "description": "BBCS intends to undertake a programme of pre-market engagement across the dates of 21/07/2026 – 05/08/2026. BBCS will make a final decision on the most appropriate route to market following completion of this engagement activity.\nAs part of this process, interested suppliers will be invited to attend a site visit to the Immunology laboratory. This site visit will be scheduled for either 21/07/2026 or 22/07/2026. This visit is intended to allow suppliers to gain an understanding of the current laboratory environment, operational workflows and space constraints within the existing laboratory.\nFollowing the site visits, suppliers will be invited to a slot to attend a virtual engagement session, and deliver a short presentation addressing points which BBCS wishes to explore. The presentations will be scheduled for either 04/08/2026 or 05/08/2026.\nDetails of the exact date and allocated time slot for the site visit and presentation will be sent to you via the Atamis portal, and all subsequent invites and information will also be provided here following the closing date.\nAtamis portal reference: \nC451727 - “UHB Immunology Managed Service - MARKET ENGAGEMENT 2026/27”"
      }
    ]
  },
  "initiationType": "tender"
}